Adjuvance Technologies

Empowering health.

Board of Directors

ADJUVANCE TECHNOLOGIES TO PRESENT AT 2021 BIO DIGITAL
ADJUVANCE TECHNOLOGIES PRESENTS DATA AT THE ANNUAL CONFERENCE ON VACCINOLOGY RESEARCH (ACVR)
ADJUVANCE TECHNOLOGIES ANNOUNCES NIH FUNDING FOR COVID-19 VACCINE RESEARCH
ADJUVANCE TECHNOLOGIES ANNOUNCES $20 MILLION SERIES A INVESTMENT FROM MORNINGSIDE VENTURE INVESTMENTS
Comparative preclinical evaluation of AS01 versus other Adjuvant systems in a candidate herpes zoster glycoprotein E subunit vaccine